Sola Diagnostics bestimmt die Risiken, an verschiedenen gynäkologischen Krebsarten zu erkranken und kontrolliert den Erfolg entsprechender präventiver Maßnahmen - bevor - der Krebs ausbricht! - Weil Krebsprävention deutlich besser ist - als Krebstherapie.
Sinsoma GmbH has the vision to make a significant contribution to a healthy and sustainable world by providing innovative molecular screening and test procedures. Sinsoma offers DNA
Since 1945, Montavit’s international business is focused on the production and distribution of pharmaceuticals and associated health related products. We are interested in sustainable and successful development of our business to safeguard our independence as a family owned company. For this reason, sustainability is a core feature of our business strategy. We have strong own brands which stimulate customer loyalty for our products and a number of reputable contract manufacturing partners.
CYPRUMED GmbH, is an Austrian drug delivery company developing enabling technologies for the non-invasive delivery of biologics, with a focus on oral peptide delivery. Key activities include formulation research, IP protection and technology out-licensing.
ViraTherapeutics develops a new class of immunotherapy drugs based on oncolytic (cancer-destroying) viruses. Our patent protected virus is designed to be safe for human beings and efficiently destroys cancer cells, while leaving normal tissues unharmed. ViraTherapeutics currently performs preclinical safety and efficacy studies for our modified Vesicular Stomatitis Virus (VSV-GP) and aims to conduct first clinical trials in cancer patients in the near future.
afreeze, headquartered in Innsbruck, Austria, is a medical device company focused on treating cardiovascular disease. Ever since it was founded by a cardiologist and an engineer, the company has been committed to providing state-of-the-art solutions to support physicians and enhance patients’ lives. The coolloop cryoablation system is a powerful and precise device to combat atrial fibrillation.
The achievement of Heart Regeneration Technologies is to refine low-energy regenerative shockwave therapy. Shockwaves at low energy levels exert regenerative effects rather than disintegration of stones or plaques such as with high energies in Lithotripsie. We developed a sterile applicator suitable for direct cardiac application during heart surgery. Our hand-held applicator is the world’s smallest shockwave applicator and there are many ideas in the pipeline.
As a manufacturer of wound care and bedding systems for patients and injured persons, therapy aides, care mattresses and decubitus prophylaxis systems, we are aware of the responsibility that results from the application of our products on sick patients and people in need of nursing care. The application of medical products for the prevention, treatment or alleviation of illnesses, injuries or handicaps requires easy and safe to use systems, providing the users with an economic aid.